Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease

Jing-Wei Zhao, Sean C Dyson, Christina Kriegel, Pam Tyers, Xiaoling He, Tarek M Fahmy, Su M Metcalfe, Roger A Barker

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science